Eventide Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-336,223
| Closed | -$2.84M | – | 149 |
|
|
2022
Q2 | $2.84M | Hold |
336,223
| – | – | 0.06% | 129 |
|
|
2022
Q1 | $4.58M | Hold |
336,223
| – | – | 0.07% | 124 |
|
|
2021
Q4 | $6.61M | Sell |
336,223
-263,777
| -44% | -$5.19M | 0.08% | 126 |
|
|
2021
Q3 | $19.3M | Hold |
600,000
| – | – | 0.25% | 96 |
|
|
2021
Q2 | $20.3M | Hold |
600,000
| – | – | 0.27% | 93 |
|
|
2021
Q1 | $22.5M | Hold |
600,000
| – | – | 0.33% | 88 |
|
|
2020
Q4 | $19.9M | Buy |
600,000
+150,000
| +33% | +$4.98M | 0.31% | 89 |
|
|
2020
Q3 | $16.5M | Hold |
450,000
| – | – | 0.32% | 84 |
|
|
2020
Q2 | $14.8M | Hold |
450,000
| – | – | 0.32% | 79 |
|
|
2020
Q1 | $11.6M | Hold |
450,000
| – | – | 0.38% | 76 |
|
|
2019
Q4 | $14M | Buy |
+450,000
| New | +$14M | 0.39% | 69 |
|